GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CHC Healthcare Group (TPE:4164) » Definitions » EV-to-EBITDA

CHC Healthcare Group (TPE:4164) EV-to-EBITDA : 9.88 (As of Dec. 15, 2024)


View and export this data going back to 2012. Start your Free Trial

What is CHC Healthcare Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CHC Healthcare Group's enterprise value is NT$11,004 Mil. CHC Healthcare Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was NT$1,114 Mil. Therefore, CHC Healthcare Group's EV-to-EBITDA for today is 9.88.

The historical rank and industry rank for CHC Healthcare Group's EV-to-EBITDA or its related term are showing as below:

TPE:4164' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.45   Med: 11.11   Max: 20.14
Current: 9.88

During the past 13 years, the highest EV-to-EBITDA of CHC Healthcare Group was 20.14. The lowest was 6.45. And the median was 11.11.

TPE:4164's EV-to-EBITDA is ranked worse than
55.56% of 90 companies
in the Medical Distribution industry
Industry Median: 9.04 vs TPE:4164: 9.88

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-15), CHC Healthcare Group's stock price is NT$41.35. CHC Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was NT$1.740. Therefore, CHC Healthcare Group's PE Ratio (TTM) for today is 23.76.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


CHC Healthcare Group EV-to-EBITDA Historical Data

The historical data trend for CHC Healthcare Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHC Healthcare Group EV-to-EBITDA Chart

CHC Healthcare Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.98 9.00 9.28 10.06 11.00

CHC Healthcare Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.00 11.00 11.79 11.89 10.52

Competitive Comparison of CHC Healthcare Group's EV-to-EBITDA

For the Medical Distribution subindustry, CHC Healthcare Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHC Healthcare Group's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CHC Healthcare Group's EV-to-EBITDA falls into.



CHC Healthcare Group EV-to-EBITDA Calculation

CHC Healthcare Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=11003.960/1113.616
=9.88

CHC Healthcare Group's current Enterprise Value is NT$11,004 Mil.
CHC Healthcare Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,114 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group  (TPE:4164) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

CHC Healthcare Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=41.35/1.740
=23.76

CHC Healthcare Group's share price for today is NT$41.35.
CHC Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.740.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


CHC Healthcare Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CHC Healthcare Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CHC Healthcare Group Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, repairs maintenance, and other services.

CHC Healthcare Group Headlines

No Headlines